Skip to content

Opening book details…

Can I read The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1) on EtoBox?

The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1) by Rupert W. Strauss; Beatriz Muñoz; Mohamed I. Ahmed; Millena Bittencourt; Etienne M. Schönbach; Michel Michaelides; David Birch; Eberhart Zrenner; Ann-Margret Ervin; Peter Charbel Issa; Jun Kong; Yulia Wolfson; Mahmood Shah; Saghar Bagheri; Sheila West; Hendrik P.N. Scholl; for the ProgStar-4 Study Group is a Medicine article available to read on EtoBox.

What is The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1) about?

**__Background/Aims:__** To describe the design and baseline characteristics of patients enrolled in the multicenter, prospective natural history study of Stargardt disease type 4. **__Methods:__** Fifteen eligible patients aged 6 years and older at baseline, harboring disease-causing variants in the __PROM1__ gene, and with specified ocular lesions were enrolled. They were examined at baseline using a standard protocol, with 6 monthly follow-up visits for a 2-year period including best-corrected ETDRS visual acuity, spectral-domain optical coherence tomography, fundus autofluorescence (FAF), mesopic and scotopic microperimetry (MP). Areas of definitely decreased FAF (DDAF) and questionably decreased FAF were outlined and quantified on FAF images. **__Results:__** Amongst the 15 patients (29 eyes) that were enrolled at 5 centers in the USA and Europe, 10 eyes (34.5%) had areas of DDAF with an average lesion area of 3.2 ± 3.5 mm^2^ (range 0.36–10.39 mm^2^) at baseline. The mean retinal sensitivity of the posterior pole derived from mesopic MP was 8.8 ± 5.8 dB. **__Conclusions:__** Data on disease progression in __PROM1__-related retinopathy from this study will contribute to the cha

Who reads The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1)?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Rupert W. Strauss; Beatriz Muñoz; Mohamed I. Ahmed; Millena Bittencourt; Etienne M. Schönbach; Michel Michaelides; David Birch; Eberhart Zrenner; Ann-Margret Ervin; Peter Charbel Issa; Jun Kong; Yulia Wolfson; Mahmood Shah; Saghar Bagheri; Sheila West; Hendrik P.N. Scholl; for the ProgStar-4 Study Group
Publisher
S. Karger AG
Published
2018
Language
EN
Field
Medicine (Health Sciences)